Glossary
Paul C Mouris
FDA Investigator Details
Paul C Mouris
Visit Investigator ProfileInvestigation Details
Last Issued Date
March 20, 2013
Conversion Rate
0
% Conversion
No. of 483’s Issued
4
Warning Letters Issued
0
Countries Inspected
USA
FDA Investigators having one site common
Detailed Analysis
Approach:
Paul C. Mouris follows a thorough and detail-oriented approach, focusing on the compliance of aseptic processing facilities and the quality control of sterile drug products. He prioritizes the adherence to written procedures and standards, especially in the context of sample testing, stability studies, and contamination control.
Profile:
Paul C. Mouris appears to have a strong focus on the aseptic processing of sterile drug products, including sample testing, stability studies, contamination control, and equipment qualification. He also pays close attention to complaint management and environmental monitoring.
Top Process Types:
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now